[ Price : $8.95]
FDA approves a supplemental BLA submitted by Janssen for Carvykti (ciltacabtagene autoleucel) to treat adults with relapsed or ref...[ Price : $8.95]
FDA sends Supernus Pharmaceuticals a second complete response letter on its NDA resubmission for the companys apomorphine infusion...[ Price : $8.95]
Federal Register notice: FDA requests nominations for voting members, excluding consumer and industry representatives, to serve on...[ Price : $8.95]
Federal Register notice: FDA announces a 6/6 public meeting entitled Financial Transparency and Efficiency of the Prescription Dru...[ Price : $8.95]
Federal Register notice: FDA determines that 24 listed drug products were not withdrawn from sale for reasons of safety or effecti...[ Price : $8.95]
FDA grants Onkos Surgical a de novo marketing authorization for its novel antibacterial coated implants.[ Price : $8.95]
Federal Register notice: FDA issues an order to debar for five years Robert Lance Shuffert from importing or offering for import a...[ Price : $8.95]
FDA approves a Bristol Myers Squibb and 2Seventy Bio supplemental BLA for Abecma (idecabtagene vicleucel; ide-cel) for treating ce...